Abstract
Doxorubicin (DOX) and daunorubicin (DAUN) are anthracycline anticancer agents; however, considerable interpatient variability exists in their pharmacokinetics. This interpatient variability is attributed in part to altered metabolism by nonsynonymous single-nucleotide polymorphisms (ns-SNPs) in genes encoding the carbonyl reductases. This study examines the effect of seven naturally occurring ns-SNPs in the CBR3 gene on in vitro metabolism of anthracyclines to doxorubicinol and daunorubicinol. Kinetic assays measure metabolite levels by high-performance liquid chromatography separation with fluorescence detection by use of purified, histidine-tagged, human CBR3 wild type and variant enzymes. The V224M, C4Y, and V93I variants resulted in significantly reduced maximal reaction velocity (Vmax) for both anthracyclines compared with the wild-type enzyme, whereas the M235L variant had significantly reduced Vmax for DOX only. Significant increases in substrate affinity were found for the V244M variant with DAUN, as well as the C4Y and V93I variants with DOX. The catalytic efficiency values for the V244M, C4Y, and V93I variants were significantly lower than the wild type for DAUN and DOX. Furthermore, DOX was observed to be a better substrate than DAUN for the wild-type enzyme and its variants. HapMap analysis indicated that a haplotype carrying the C4Y and V244M mutations may occur in some individuals in the 11 ethnic populations studied in the HapMap project. Our preparation of the double mutant indicated a significant reduction in activity compared with the wild-type enzyme and single-mutant preparations. These findings suggest that commonly occurring ns-SNPs in human CBR3 significantly alter the in vitro metabolism of DOX and DAUN.
Footnotes
This work was supported by the Canadian Institutes of Health Research [Grant MOP-68896]; and a Canadian Institutes of Health Research Doctoral Research Award (to O.S.B.).
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
doi:10.1124/jpet.109.160614.
↵ The online version of this article (available at http://jpet.aspetjournals.org) contains supplemental material.
-
ABBREVIATIONS:
- CBR
- carbonyl reductase
- DOX
- doxorubicin
- DAUN
- daunorubicin
- DOXol
- doxorubicinol
- DAUNol
- daunorubicinol
- SNP
- single-nucleotide polymorphism
- ns-SNP
- nonsynonymous single-nucleotide polymorphism
- HPLC
- high-performance liquid chromatography
- PAGE
- polyacrylamide gel electrophoresis
- FXa
- Factor Xa
- PCR
- polymerase chain reaction
- IPTG
- β-d-1-thiogalactopyranoside
- LOD
- logarithm of odds ratio
- Ni-NTA
- nickel-nitrilotriacetic acid affinity.
- Received August 17, 2009.
- Accepted December 8, 2009.
- Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|